Teladoc Health Inc (TDOC)
$12.73
0.17 (1.32%)
TDOC Stock Quote Delayed 30 Minutes
Teladoc Health Looks Like a Series of Red Flags
TDOC stock has been beaten down in 2022, and the fundamentals suggest more pain is likely after the company lowered its 2022 guidance.
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
2.08B
PE Ratio
-9.03
EPS
-1.41
Volume (Avg. Vol.)
3.36M
Day's Range
$12.55 - $12.86
52-Week Range
$11.88 - $30.41
Dividend & Yield
N/A (N/A)
TDOC Stock Predictions, Articles, and Teladoc Health Inc News
Stay Away From Unhealthy Teladoc Stock
After digging into the telehealth company's financials, you won't want to book an appointment with TDOC stock.
Teladoc Health Is Overvalued After Its Sell-Off
TDOC stock is like a falling knife now. Trying to catch Teledoc at this point is dangerous, risky and without any logic.
Roblox Stock May Have Bottomed
Roblox has been cruising higher following disappointing earnings. The strength could be signaling the bottom is in for RBLX stock.
Why Teladoc Stock Does Not Have a Cure Right Now
A tougher competitive landscape, plus a market less favorable to growth plays means a bad prognosis remains for TDOC stock.
Investors Should Take a Bigger Position When Teledoc Posts a Strong Quarter
First-quarter revenue miss reset Teladoc’s prospects for shareholders, pressuring the company to accelerate its multi-product launch.
Teladoc Health’s Vital Signs Are Not Getting Better
Teladoc has been caught up in the wave as the tech sector has sunk. But it's getting increasingly hard to dismiss TDOC stock's specific flaws, as well.
Cathie Wood Bought Teladoc (TDOC) Stock on the Dip. Here’s Why.
Despite falling by over 40% yesterday, Cathie Wood's Ark Invest reported purchasing an additional 609,665 shares of TDOC stock.
Teladoc Stock Is Not as Toxic as It Seems
TDOC stock fell into contentious levels with levels from the IPO days. Initiating starter positions now makes a bit of speculative sense.
Teladoc Faces an Arduous Task After Revenue Miss
It's not a good time to own growth stocks such as Teladoc. Teladoc's sales cycle is eroding amid a changing economic climate, thus leaving its stock overvalued.
Why Is the Ark Innovation (ARKK) ETF Plunging Today?
Cathie Wood's Ark Innovation (ARKK) is falling hard on Thursday as one of the ETF's biggest holdings drops alongside earnings today.
Is TDOC Stock a Buy After Its Earnings Plunge? 3 Analysts Weigh In on Teladoc.
Teladoc (TDOC) stock isn't doing so hot Thursday following its earnings report and some investors are wondering if shares are worth buying.
